In the human neuroblastoma cell line SHSY5Y and prostate cancer PC3 cells, the downregulation of CtBP2 inhibited cell proliferation and arrested the cell cycle, by decreasing the expression of c-Myc (Zhang et al., 2014; Nan et al., 2017). Here, MYC is linked to prostate carcinoma.